 | ||||
| ||||
 | ||||
| It can be a struggle to keep up with important developments in therapeutics. That’s why coverage of new drug-related evidence is an important feature of NEJM Journal Watch, helping us fulfill our mission to support clinicians’ efficient understanding of medical developments. Our 110 NEJM Journal Watch physician-editors regularly appraise a broad range of medication studies, choose those with the most clinical impact, and summarize them, highlighting key points and identifying what’s new. |
Tuesday, April 11, 2017
NEJM: 2017 Drug Research
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment